Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds
Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers
Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds
GSK HPV Vaccine Offers Protection From 4 HPV Types
Aspirin Use Associated With Lower Cancer Indicence, Death
Early ADT Doesn’t Offer Survival Advantage—ASCO
Gleevec Decreases Recurrence Of Gastrointestinal Tumor
NCI-Approved Cancer Center, Cooperative Group Trials
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case









